Novo Holdings on Asia Biotech Opportunities

The video discusses a biotech investment firm with $75 billion in assets, focusing on Asia's growing market. The firm has made several investments in biotech and digital health in Southeast Asia, with plans to expand in China despite regulatory uncertainties. Key focus areas include chronic diseases, oncology, and sustainability. The video also highlights the role of capital markets in biotech development, particularly in China and Hong Kong.

What types of diseases does the speaker indicate a growing demand for in their investment strategy?

What unique perspective does the speaker mention regarding investments related to the circular economy?

What challenges does the speaker identify regarding the capital markets in Southeast Asia?